DK0588539T3 - Stabiliserede farmaceutiske præparater indeholdende derivater af vitamin D2 og D3 - Google Patents
Stabiliserede farmaceutiske præparater indeholdende derivater af vitamin D2 og D3Info
- Publication number
- DK0588539T3 DK0588539T3 DK93306978.3T DK93306978T DK0588539T3 DK 0588539 T3 DK0588539 T3 DK 0588539T3 DK 93306978 T DK93306978 T DK 93306978T DK 0588539 T3 DK0588539 T3 DK 0588539T3
- Authority
- DK
- Denmark
- Prior art keywords
- vitamins
- pharmaceutical preparations
- preparations containing
- containing derivatives
- stabilized pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/592—9,10-Secoergostane derivatives, e.g. ergocalciferol, i.e. vitamin D2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nutrition Science (AREA)
- Endocrinology (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL10322492A IL103224A (en) | 1992-09-18 | 1992-09-18 | Stabilized pharmaceutical compositions containing derivatives of vitamins d2 and d3 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0588539T3 true DK0588539T3 (da) | 1997-03-10 |
Family
ID=11064050
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK93306978.3T DK0588539T3 (da) | 1992-09-18 | 1993-09-03 | Stabiliserede farmaceutiske præparater indeholdende derivater af vitamin D2 og D3 |
Country Status (12)
Country | Link |
---|---|
US (2) | US5565442A (da) |
EP (1) | EP0588539B1 (da) |
JP (1) | JP3464691B2 (da) |
AT (1) | ATE148630T1 (da) |
AU (1) | AU667742B2 (da) |
CA (1) | CA2106423C (da) |
DE (1) | DE69307977T2 (da) |
DK (1) | DK0588539T3 (da) |
ES (1) | ES2098672T3 (da) |
GR (1) | GR3023127T3 (da) |
IL (1) | IL103224A (da) |
ZA (1) | ZA936835B (da) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9325445D0 (en) | 1993-12-13 | 1994-02-16 | Cortecs Ltd | Pharmaceutical formulations |
JP2656448B2 (ja) * | 1994-07-25 | 1997-09-24 | マイクロアルジェコーポレーション株式会社 | カルシウムを主成分とする健康食品 |
DE19710054A1 (de) * | 1997-03-12 | 1998-09-17 | Merck Patent Gmbh | Pharmazeutische Zubereitung |
ITFI970184A1 (it) * | 1997-07-30 | 1999-01-30 | Menarini Farma Ind | Composizioni farmaceutiche contenenti vitamina d e calcio,loro preparazione ed uso terapeutico |
JP2004504295A (ja) * | 2000-07-18 | 2004-02-12 | ボーン ケア インターナショナル インコーポレイテッド | 安定化1α−ヒドロキシビタミンD |
US6475526B1 (en) | 2001-06-05 | 2002-11-05 | Jeffrey B. Smith | Zinc containing compositions for anti-viral use |
US8101209B2 (en) | 2001-10-09 | 2012-01-24 | Flamel Technologies | Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles |
DE60325709D1 (de) | 2002-04-09 | 2009-02-26 | Flamel Tech Sa | Orale wässrige suspension, mikrokapseln enthaltend, zur kontrollierten freisetzung von wirkstoffen |
AU2003246791A1 (en) * | 2002-04-09 | 2003-10-20 | Flamel Technologies | Oral suspension of amoxicillin capsules |
US20040053895A1 (en) * | 2002-09-18 | 2004-03-18 | Bone Care International, Inc. | Multi-use vessels for vitamin D formulations |
US20040058895A1 (en) * | 2002-09-18 | 2004-03-25 | Bone Care International, Inc. | Multi-use vessels for vitamin D formulations |
US7148211B2 (en) * | 2002-09-18 | 2006-12-12 | Genzyme Corporation | Formulation for lipophilic agents |
US6855341B2 (en) * | 2002-11-04 | 2005-02-15 | Jeffrey B. Smith | Anti-viral compositions and methods of making and using the anti-viral compositions |
US20080274209A1 (en) * | 2002-11-04 | 2008-11-06 | Integritas Pharma, Inc. | Methods of treating inflammation |
US20060189586A1 (en) * | 2003-06-11 | 2006-08-24 | Cleland Jeffrey L | Pharmaceutical compositions comprising active vitamin D compounds |
JP2007532629A (ja) | 2004-04-15 | 2007-11-15 | キアスマ, インコーポレイテッド | 生物学的障壁を横切る透過を促進し得る組成物 |
US7700365B2 (en) | 2004-10-29 | 2010-04-20 | Mayo Foundation For Medical Education And Research | Vitamin D deficiencies |
FR2889810A1 (fr) * | 2005-05-24 | 2007-02-23 | Flamel Technologies Sa | Forme medicamenteuse orale, microparticulaire, anti-mesurage |
EP2262765B1 (en) * | 2008-03-12 | 2016-03-09 | OPKO Ireland Global Holdings, Limited | Stabilized 1,25-dihydroxyvitamin d2 and method of making same |
WO2010019566A2 (en) * | 2008-08-11 | 2010-02-18 | Mayo Foundation For Medical Education And Research | Methods for determining levels of 1,25 dihydroxy vitamin d2 and d3 |
JP5623406B2 (ja) | 2008-09-17 | 2014-11-12 | キアズマ インコーポレイテッド | 医薬組成物および関連する送達方法 |
BRPI1007415A2 (pt) | 2009-01-27 | 2016-02-16 | Berg Biosystems Llc | vitamina d3 e análogos da mesma para aliviar os efeitos colaterais associados com quimioterapia |
CA2770683C (en) | 2009-08-14 | 2018-09-04 | Berg Biosystems, Llc | Vitamin d3 and analogs thereof for treating alopecia |
EP2468265A3 (en) * | 2010-12-04 | 2013-01-02 | DEEF Pharmaceutical Industries Co. | Homogeneous preparations containing vitamin D |
EP2978431A4 (en) | 2013-03-27 | 2016-08-24 | Psm Healthcare Ltd | STABILIZED FORMULATIONS OF VITAMIN D |
SG11201509715UA (en) | 2013-05-29 | 2015-12-30 | Berg Llc | Preventing or mitigating chemotherapy induced alopecia using vitamin d |
US11071743B1 (en) * | 2015-01-16 | 2021-07-27 | Gregory M. Fahy | Effective, non-toxic treatments for brain cancer |
WO2016126830A1 (en) | 2015-02-03 | 2016-08-11 | Chiasma Inc. | Method of treating diseases |
US11141457B1 (en) | 2020-12-28 | 2021-10-12 | Amryt Endo, Inc. | Oral octreotide therapy and contraceptive methods |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3932634A (en) * | 1973-06-28 | 1976-01-13 | Pfizer Inc. | High potency vitamin water dispersible formulations |
JPS58206533A (ja) * | 1982-05-27 | 1983-12-01 | Teijin Ltd | 活性型ビタミンd↓3誘導体組成物及びそれを活性成分とする薬剤 |
JPS59155309A (ja) * | 1983-02-22 | 1984-09-04 | Teijin Ltd | 活性型ビタミンd↓3類組成物 |
CA1272953A (en) * | 1984-10-08 | 1990-08-21 | Yuji Makino | Pharmaceutical composition for external use containing active-type vitamin d.sub.3 |
CA1317546C (en) * | 1985-07-01 | 1993-05-11 | Werner Meier | Pharmaceutical preparations containing mixtures of hydroxy derivatives of vitamin d |
JPS62149619A (ja) * | 1985-09-05 | 1987-07-03 | Teijin Ltd | 活性型ビタミンd3類注射用組成物 |
DD266099A1 (de) * | 1987-09-28 | 1989-03-22 | Jenapharm Veb | Verfahren zur herstellung von stabilen waessrigen vitamin-d-loesungen |
JPH0331257Y2 (da) * | 1987-10-31 | 1991-07-02 | ||
JP2525478B2 (ja) * | 1989-03-01 | 1996-08-21 | 帝人株式会社 | 安定性の改良された活性型ビタミンd▲下3▼類固型製剤 |
JPH02240024A (ja) * | 1989-03-13 | 1990-09-25 | Ss Pharmaceut Co Ltd | 活性型ビタミンd↓3類製剤用組成物 |
ATE99942T1 (de) * | 1989-05-18 | 1994-01-15 | Hoffmann La Roche | Dehydrocholecalciferolderivate. |
ATE104554T1 (de) * | 1990-01-10 | 1994-05-15 | Hoffmann La Roche | Topische praeparate. |
JP2963718B2 (ja) * | 1990-03-06 | 1999-10-18 | グレラン製薬株式会社 | ビタミンd▲下3▼類含有製剤 |
JP2787364B2 (ja) * | 1990-03-29 | 1998-08-13 | 大塚製薬株式会社 | 脂溶性ビタミン注射液 |
JP2845342B2 (ja) * | 1990-04-28 | 1999-01-13 | 大正製薬株式会社 | ビタミンd▲下3▼誘導体含有固形製剤組成物 |
JP2974734B2 (ja) * | 1990-07-12 | 1999-11-10 | 中外製薬株式会社 | 安定な活性型ビタミンd▲下3▼類製剤 |
JPH04198129A (ja) * | 1990-11-28 | 1992-07-17 | Sumitomo Pharmaceut Co Ltd | 活性型ビタミンd↓3類含有組成物 |
-
1992
- 1992-09-18 IL IL10322492A patent/IL103224A/en not_active IP Right Cessation
-
1993
- 1993-09-03 AT AT93306978T patent/ATE148630T1/de not_active IP Right Cessation
- 1993-09-03 EP EP93306978A patent/EP0588539B1/en not_active Expired - Lifetime
- 1993-09-03 ES ES93306978T patent/ES2098672T3/es not_active Expired - Lifetime
- 1993-09-03 DE DE69307977T patent/DE69307977T2/de not_active Expired - Lifetime
- 1993-09-03 DK DK93306978.3T patent/DK0588539T3/da active
- 1993-09-13 US US08/120,210 patent/US5565442A/en not_active Expired - Lifetime
- 1993-09-16 AU AU47408/93A patent/AU667742B2/en not_active Ceased
- 1993-09-16 ZA ZA936835A patent/ZA936835B/xx unknown
- 1993-09-17 CA CA002106423A patent/CA2106423C/en not_active Expired - Fee Related
- 1993-09-20 JP JP23389093A patent/JP3464691B2/ja not_active Expired - Fee Related
-
1996
- 1996-05-31 US US08/657,676 patent/US5804573A/en not_active Expired - Lifetime
-
1997
- 1997-04-14 GR GR970400788T patent/GR3023127T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
JPH06219952A (ja) | 1994-08-09 |
IL103224A0 (en) | 1993-02-21 |
IL103224A (en) | 1998-08-16 |
DE69307977D1 (de) | 1997-03-20 |
EP0588539A1 (en) | 1994-03-23 |
JP3464691B2 (ja) | 2003-11-10 |
ES2098672T3 (es) | 1997-05-01 |
US5565442A (en) | 1996-10-15 |
GR3023127T3 (en) | 1997-07-30 |
CA2106423A1 (en) | 1994-03-19 |
ATE148630T1 (de) | 1997-02-15 |
AU667742B2 (en) | 1996-04-04 |
DE69307977T2 (de) | 1997-08-28 |
CA2106423C (en) | 2005-02-22 |
ZA936835B (en) | 1994-04-14 |
US5804573A (en) | 1998-09-08 |
AU4740893A (en) | 1994-03-24 |
EP0588539B1 (en) | 1997-02-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0588539T3 (da) | Stabiliserede farmaceutiske præparater indeholdende derivater af vitamin D2 og D3 | |
NZ244021A (en) | Benzylthiazolidinedione derivatives, preparation and pharmaceutical compositions thereof | |
NO991152D0 (no) | Stabil farmas°ytisk blanding inneholdende 4,5-epoksy-morfinan-derivat | |
TW355683B (en) | Composition containing micronized nebivolol | |
ZA92302B (en) | Optically active 5h-pyrrolo-(3,4-b)pyrazine derivative,its preparation and pharmaceutical compositions containing it | |
ZA885192B (en) | Pharmaceutical preparations | |
IL100899A0 (en) | Beta-amino-alpha-hydroxycarboxylic acid derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same | |
IL101883A0 (en) | Antiviral combinations and pharmaceutical compositions containing them | |
TW234691B (da) | ||
IL109901A (en) | Peptidic phosphinyloxymethyl ketones and pharmaceutical compositions containing them | |
IL105942A0 (en) | Biologically active eburnamenine derivatives,their preparation and pharmaceutical compositions containing them | |
AU4429885A (en) | Solid medicament formulations containing dihydropyridines | |
IL92187A0 (en) | Anti-human immunodeficiency virus compositions comprising fluorine-containing pyridonecarboxylic acid derivatives | |
DE69019035D1 (de) | Stabilisierte fettlösliche Vitaminzusammensetzungen. | |
EP0515995A3 (en) | N-(5-thioxo-l-prolyl)-l-cysteine, derivatives thereof, processes for the preparation thereof and pharmaceutical compositions containing them | |
IL87778A0 (en) | Pharmaceutical compositions containing stabilized therapeutically active proteins and their preparation | |
DK0524696T3 (da) | Orale præparater indeholdende dapiprazol | |
EP0419890A3 (en) | Stable pharmaceutical formulations for antineoplastic compounds having more than one ethyleneimine group, and method | |
IL106289A0 (en) | Phospholipid derivatives, their preparation and pharmaceutical compositions containing them | |
DK0626173T3 (da) | Aerosolpræparat indeholdende fusafungin | |
HK135494A (en) | Azelastin embonate, process for its preparation and pharmaceutical compositions containing azelastin embonate as the active ingredient | |
IL90191A0 (en) | 3-pyrrolidinylthio-1-azabicyclo-(3.2.0)hept-2-ene-2-carboxylic acid derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same | |
DK0508311T3 (da) | Injicerbare præparater indeholdende 2-oxindol-1-carboxamidderivater | |
IT1254453B (it) | Composizioni farmaceutiche per uso orale a base di glutatione ridotto | |
IT1254938B (it) | Derivati otticamente attivi della n-imminoalchil-n'-((2-idrossi- 2-fenil-2-cicloesil)-etil)-piperazina |